Volume 364 Number 9435 August 21–27, 2004
The Lancet – London
637 How complicit are doctors in abuses of detainees? 665 Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications 675 Comparison of lumiracoxib with naproxen and ibuprofen The Lancet – New York
639 A coxib a day won’t keep the doctor away in the Therapeutic Arthritis Research and Gastrointestinal 641 Statins for all patients with type 2 diabetes: not so soon Event Trial (TARGET), cardiovascular outcomes 642 Tonsillectomy technique—tradition versus technology 685 Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the CollaborativeAtorvastatin Diabetes Study (CARDS) 644 Nosocomial bacteraemia caused by Staphylococcus aureus 645 Women undergoing termination of pregnancy should be 697 Tonsillectomy technique as a risk factor for postoperative screened for gestational trophoblastic neoplasia haemorrhageNational Prospective Tonsillectomy Audit Research Letters
703 Risk and outcome of nosocomial Staphylococcus aureus 648 Rabies transmission from organ transplants in the USA Deputy editor
bacteraemia in nasal carriers versus non-carriers Executive editors
649 Is repeated caesarean section a consequence of elective 705 Routine terminations of pregnancy—should we screen World Report
Clinical Picture
Managing editor
Senior editors
709 Pathophysiology of airflow limitation in chronic 655 Book: Reclaiming dignity from despair in Alzheimer’s Rapid Review
722 Pathogenetic mechanisms of parkin in Parkinson’s North American editor
Michael McCarthy (Seattle)T +1 206 706 7461 North American senior editor
Health and Human Rights
European senior editor
725 Abu Ghraib: its legacy for military medicine Obituary
Case Report
Senior assistant editors
Assistant editors
659 Use of selective serotonin reuptake inhibitors in childhood depressionT Wohlfarth and others; F Curtin, P Schulz; A J Salerian; C J Whittington and others Editorial researcher
Rachael Davies
Editorial assistant
C W Baker; J J Segall; J Mann; M L Wahlqvist 663 Outdoor air pollution: the effects of ozone Web content coordinator
Contributing editors
Dorothy Bonn
Peer reviewed and fast-tracked to publication in 4 weeks Information for authors:
International Advisory Board
Karen Antman (New York)
For personal use. Only reproduce with permission from Elsevi

Source: http://www.sterne-und-weltraum.de/sixcms/media.php/254/Contents%20Aug%2021%5B1%5D.pdf


PUREPAC PHARMACEUTICAL CO., Plaintiff-Appellee, v., 2003 WL 25585736. 2003 WL 25585736 (C.A.D.C.) (Appellate Brief)United States Court of Appeals, District of Columbia Circuit. PUREPAC PHARMACEUTICAL CO., Plaintiff-Appellee,Tommy G. THOMPSON, Secretary of Health and Human Services, and MarkB. McClellan, Commissioner of Food and Drugs, Defendants-Appellees,Torpharm, Inc. and Apotex, Inc., I


Press release For immediate release WATER-JEL, PROFESSIONAL TREATMENT FOR EVERYDAY BURNS, --Widespread use in fire fighting and emergency medical fields for 20 years (Chicago-October, 2002)- Every 25 seconds someone in the United Statesis burned or scalded in their home, according to the American Burn Associationand the Burn Foundation. Burn-Jel and Water-Jel, two hydro-based gel products, h

Copyright © 2010 Find Medical Article